河北医学
河北醫學
하북의학
HEBEI MEDICINE
2014年
4期
611-614
,共4页
余辉%吴楠%王树鹤%高桂卿
餘輝%吳楠%王樹鶴%高桂卿
여휘%오남%왕수학%고계경
宫颈癌%新辅助化疗%DBM方案%动脉灌注化疗
宮頸癌%新輔助化療%DBM方案%動脈灌註化療
궁경암%신보조화료%DBM방안%동맥관주화료
Cervical cancer%Neoadjuvant chemotherapy%DBM therapy%Arterial infusion chemotherapy
目的:探讨早期宫颈癌新辅助化疗的疗效和安全性。方法:选择Ib1期至IIb期宫颈癌39例,采用DBM方案动脉灌注化疗1-2个疗程后,行腹腔镜下广泛性子宫切除术及盆腔淋巴结清扫术;观察化疗前后癌灶的变化、化疗副反应及术后病理结果等指标。结果:全部病例化疗后宫颈局部肿瘤直径均不同程度缩小,化疗有效率100%;3例IIb期宫旁病灶改善不满意直接行放疗,其余36例行腹腔镜下宫颈癌根治术;手术成功率100%;有12例(12/36)术后病理结果未发现癌灶。主要毒副反应为消化道症状及I-II度白细胞减少,用药后可缓解。结论:宫颈癌新辅助化疗近期疗效好,副反应轻。
目的:探討早期宮頸癌新輔助化療的療效和安全性。方法:選擇Ib1期至IIb期宮頸癌39例,採用DBM方案動脈灌註化療1-2箇療程後,行腹腔鏡下廣汎性子宮切除術及盆腔淋巴結清掃術;觀察化療前後癌竈的變化、化療副反應及術後病理結果等指標。結果:全部病例化療後宮頸跼部腫瘤直徑均不同程度縮小,化療有效率100%;3例IIb期宮徬病竈改善不滿意直接行放療,其餘36例行腹腔鏡下宮頸癌根治術;手術成功率100%;有12例(12/36)術後病理結果未髮現癌竈。主要毒副反應為消化道癥狀及I-II度白細胞減少,用藥後可緩解。結論:宮頸癌新輔助化療近期療效好,副反應輕。
목적:탐토조기궁경암신보조화료적료효화안전성。방법:선택Ib1기지IIb기궁경암39례,채용DBM방안동맥관주화료1-2개료정후,행복강경하엄범성자궁절제술급분강림파결청소술;관찰화료전후암조적변화、화료부반응급술후병리결과등지표。결과:전부병례화료후궁경국부종류직경균불동정도축소,화료유효솔100%;3례IIb기궁방병조개선불만의직접행방료,기여36례행복강경하궁경암근치술;수술성공솔100%;유12례(12/36)술후병리결과미발현암조。주요독부반응위소화도증상급I-II도백세포감소,용약후가완해。결론:궁경암신보조화료근기료효호,부반응경。
Objective:To evaluate the response and security to neoadjuvant chemotherapy ( NACT) in patients of Ib1-IIb cervical cancer .Method:A retrospective study were made on 39 cervical cancer patients ( FIGO stage Ib1-IIb) underwent this DBM therapy by arterial infusion chemotherapy for 1 or 2 courses and followed by radical hysterectomy .The observation indexes included the change of the local lesion , side effect and pathological outcomes after the surgery .Result: All the patients indicated reduction of the lesions .the effective rate was 100%.Except 3 patients in IIb stage took radiotherapy , the rest take laparoscopic radical operation.The success rate of operation was 100%.There’re 12 (12/36) pathological reports showed that no cancer residue were detected .The main side effects were symptom of digestive tract like nausea and vomiting and I-II degree leucocytopenia .All these symptoms could be remittent after the symptomatic treatment .Con-clusion:Neoadjuvant chemotherapy ( NACT) is effective in short-term efficacy and the side effect is tolera-ble.